Trends in industry-sponsored clinical trial activity since passage of the Inflation Reduction Act

While descriptive, this study offers early evidence of reductions in industry-sponsored new small molecule pre-approval and post-approval drug trials after IRA passage. These trends should be monitored as responses work their way through drug pipeline investment decisions.